Inventor · disambiguated record
Lai-Xi Wang
Also filed as: WANG LAI · WANG LAI-XI
40 granted patents·13 pending applications·294 citations·filing 2003–2024
98Inventor score
Files withUNIV MARYLAND18BEIGENE SWITZERLAND GMBH7BEIGENE LTD6UNIV MARYLAND BIOTECH INST5WANG Lai Xi3
Top patents by PatentIndex Score
53 records- 0198US9850473B2Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from Streptococcus pneumoniaeUNIV MARYLAND·Filed 2015·Granted Dec 26, 2017·16 cites·5 claims
- 0297US11591340B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Feb 28, 2023·6 cites·27 claims
- 0397US9434786B2Chemoenzymatic glycoengineering of antibodies and Fc fragments thereofUNIV MARYLAND·Filed 2013·Granted Sep 6, 2016·40 cites·11 claims
- 0496US8354247B2Glycoprotein synthesis and remodeling by enzymatic transglycosylationUNIV MARYLAND·Filed 2010·Granted Jan 15, 2013·16 cites·6 claims
- 0594US11845970B2Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteinsUNIV MARYLAND·Filed 2021·Granted Dec 19, 2023·2 cites·12 claims
- 0694US9845360B2Chemoenzymatic glycoengineering of antibodies and Fc fragments thereofUNIV MARYLAND·Filed 2016·Granted Dec 19, 2017·8 cites·1 claims
- 0793US11643450B2Chemoenzymatic glycoengineering of antibodies and Fc fragments thereofUNIV MARYLAND·Filed 2020·Granted May 9, 2023·2 cites·8 claims
- 0893US10864203B2Combination of a PD-1 antagonist and a RAF inhibitor for treating cancerBEIGENE LTD·Filed 2017·Granted Dec 15, 2020·10 cites·13 claims
- 0993US10836805B2Chemoenzymatic glycoengineering of antibodies and FC fragments thereofUNIV MARYLAND·Filed 2019·Granted Nov 17, 2020·4 cites·11 claims
- 1093US8900826B2Glycoprotein synthesis and remodeling by enzymatic transglycosylationWANG LAI-XI·Filed 2013·Granted Dec 2, 2014·15 cites·3 claims
- 1193US7807405B2Glycoprotein synthesis and remodeling by enzymatic transglycosylationUNIV MARYLAND BALTIMORE OFFICE·Filed 2007·Granted Oct 5, 2010·27 cites·9 claims
- 1293US7728106B2HIV-1 glycopeptides and derivatives; preparation and applications thereofUNIV MARYLAND BIOTECH INST·Filed 2006·Granted Jun 1, 2010·18 cites·11 claims
- 1392US11202782B2Treatment cancers using a combination comprising PARP inhibitorsBEIGENE LTD·Filed 2017·Granted Dec 21, 2021·9 cites·29 claims
- 1492US7604804B2Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120UNIV MARYLAND BIOTECH INST·Filed 2005·Granted Oct 20, 2009·17 cites·21 claims
- 1591US10344063B2Chemoenzymatic glycoengineering of antibodies and Fc fragments thereofUNIV MARYLAND·Filed 2017·Granted Jul 9, 2019·7 cites·6 claims
- 1691US9605050B2Glycoprotein synthesis and remodeling by enzymatic transglycosylationUNIV MARYLAND·Filed 2014·Granted Mar 28, 2017·6 cites·4 claims
- 1791US9175326B2Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from streptococcus pneumoniaeUNIV MARYLAND·Filed 2013·Granted Nov 3, 2015·8 cites·11 claims
- 1889US7622106B1Necrosis assayUNIV TEXAS·Filed 2009·Granted Nov 24, 2009·15 cites·8 claims
- 1988US11970500B1Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2023·Granted Apr 30, 2024·0 cites·28 claims
- 2088US11008601B2Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteinsUNIV MARYLAND·Filed 2017·Granted May 18, 2021·3 cites·18 claims
- 2187US11597768B2Immunotherapy for hepatocellular carcinomaBEIGENE LTD·Filed 2018·Granted Mar 7, 2023·7 cites·13 claims
- 2287US11193155B2Designer α 6-fucosidase mutants enable direct core fucosylation of intact N-glycopeptides and N-glycoproteinsUNIV MARYLAND·Filed 2017·Granted Dec 7, 2021·3 cites·11 claims
- 2385US7524821B2Scaffolded maleimide clusters for multivalent peptide assemblyUNIV MARYLAND BIOTECH INST·Filed 2003·Granted Apr 28, 2009·22 cites·10 claims
- 2485US2023242542A1COMPOSITIONS COMPRISING (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDEBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 2584US11701357B2Treatment of B cell cancers using a combination comprising Btk inhibitorsBEIGENE SWITZERLAND GMBH·Filed 2017·Granted Jul 18, 2023·4 cites·19 claims
- 2684US11534431B2Combination of a PD-1 antagonist and a RAF inhibitor for treating cancerBEIGENE LTD·Filed 2020·Granted Dec 27, 2022·1 cites·21 claims
- 2784US7556806B2Carbohydrate-based synthetic vaccines for HIVUNIV MARYLAND BIOTECH INST·Filed 2003·Granted Jul 7, 2009·14 cites·10 claims
- 2883US11884674B2Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Granted Jan 30, 2024·0 cites·28 claims
- 2983US11459380B2Transglycosylation of endo-S and endo-S mutants for antibody glycosylation remodelingUNIV MARYLAND·Filed 2018·Granted Oct 4, 2022·2 cites·5 claims
- 3083US10836815B2Generation and comparative kinetic analysis of new glycosynthase mutants from Streptococcus pyogenes endoglycosidases for antibody glycoengineeringUNIV MARYLAND·Filed 2018·Granted Nov 17, 2020·2 cites·10 claims
- 3182US8551955B2Dimeric Smac mimeticsSUN HAIZHOU·Filed 2010·Granted Oct 8, 2013·4 cites·20 claims
- 3277US12497643B2Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteinsUNIV MARYLAND·Filed 2023·Granted Dec 16, 2025·0 cites·12 claims
- 3376US2024335553A1Fc GLYCAN REMODELING PLATFORM METHOD FOR SITE-SPECIFIC ANTIBODY CONJUGATION AND APPLICATIONS THEREOFUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 3474US7989482B2Indoline anti-cancer agentsJOYANT PHARMACEUTICALS INC·Filed 2009·Granted Aug 2, 2011·2 cites·18 claims
- 3573US12139509B2Fc glycan remodeling platform method for site-specific antibody conjugation and applications thereofUNIV MARYLAND·Filed 2023·Granted Nov 12, 2024·0 cites·10 claims
- 3672US10851174B2Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereofWANG Lai Xi·Filed 2012·Granted Dec 1, 2020·3 cites·19 claims
- 3772US8846734B2Diazonamide analogsJOYANT PHARMACEUTICALS INC·Filed 2013·Granted Sep 30, 2014·1 cites·9 claims
- 3869US2023364096A1Use of a combination comprising a btk inhibitor for treating cancersBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 3958US2024218342A1Site-specific glycan remodeling of lysosomal enzymes and applications thereofWANG Lai Xi·Filed 2022·Application pending·0 cites
- 4054US8465976B2Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavitySHARIFI BEHROOZ·Filed 2008·Granted Jun 18, 2013·0 cites·9 claims
- 4154US8334311B2Indoline anti-cancer agentsHANSON GUNNAR JAMES·Filed 2011·Granted Dec 18, 2012·0 cites·19 claims
- 4252US2013344026A1Dimeric Smac MimeticsSUN HAIZHOU·Filed 2013·Application pending·0 cites
- 4349US2010173323A1Glycosylation engineered antibody therapyUNIV MARYLAND·Filed 2007·Application pending·0 cites
- 4448US2023089557A1Methods of treating dlbcl using btk inhibitors and combinations thereofBEIGENE SWITZERLAND GMBH·Filed 2021·Application pending·0 cites
- 4547US2020155567A1Treatment of cancers using a combination comprising parp inhibitors, temozolomide and/or radiation therapyBEIGENE LTD·Filed 2018·Application pending·0 cites
- 4646US2010221241A1Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sitesUNIV MARYLAND BIOTECH INST·Filed 2006·Application pending·0 cites
- 4745US10905702B2Inhibition of galectin 3 binding to the airway epithelial surface to treat or prevent septic shock resulting from influenza and subsequent pneumococcal pneumonia infectionVASTA GERARDO·Filed 2019·Granted Feb 2, 2021·0 cites·24 claims
- 4843US2008268478A1Use of Eotaxin as a Diagnostic Indicator For Atherosclerosis and Vascular InflammationCEDARS SINAI MEDICAL CENTER·Filed 2006·Application pending·0 cites
- 4942US2014348865A1Immunogens based on an hiv-1 v1v2 site-of-vulnerabilityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2012·Application pending·0 cites
- 5041US8592469B2Diazonamide analogsWEI QI·Filed 2012·Granted Nov 26, 2013·0 cites·20 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lai-Xi Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →